CLINICAL_TRIALS
trial_result
· 2025-06-13
Clinical Trial Update: A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) [Phase 2, Phase 3]
Summary
A Phase 2/3 trial of Unesbulin in advanced leiomyosarcoma was terminated, with results posted on 2025-06-13.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Leiomyosarcoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-06-13